NCT04929028 2026-04-13
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Cedars-Sinai Medical Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
University of Miami
Istanbul University